摘要
目的：进一步探索中药联合免疫抑制疗法[环孢素A（CsA）联合康力龙]治疗再生障碍性贫血（从）的临床疗效。方法：将2007年4月～2010年4月在我院确诊并接受治疗的患者42例随机分为对照组（22例）和治疗组（20例）。对照组采用免疫抑制治疗方法；治疗组在免疫抑制治疗的基础上加用中药治疗。观察两组治疗方法的疗效。结果：对照组治疗后达到基本治愈者4例（18.2％），缓解3例（13.6％），明显进步6例（27.3％），无效9例（40.9％），总有效率59.1％，观察期间有4例患者因严重感染死亡。治疗组治疗后达到基本治愈者6例（30.0％），缓解5例（25.O％），明显进步4例（20.0％），无效5例（25.0％），总有效率75.0％，观察期间有1例患者因脑出血死亡。结论：中药联合免疫抑制治疗AA效果优于单独免疫抑制疗法（P〈O.05），值得在临床进一步推广。
Objective：To analyze the outcome of aplastic anemia received traditional chinese medicine and CsA combined therapy. Methods：The clinical data of 42 patients with aplastic anemia（AA） in our hospital fi＇om April 2007 to April 2010.42 Patients were divided into two groups：the control group including 22 patients received CsA therapy only,the treatment group including 20 patients received traditional chinese medicine and CsA combined therapy.Result：The total effective rate of the control group was 59.1%,and 75.0% of the treatment group （P 〈0.05）.During the observation,there was 1 patient died of cerebral hemorrhage in the treatment group,and 4 patients died of serious infection in the contrel group.Conclusion：The outcome of patients received traditional chinese medicine and CsA combined therapy is better than the outcomes ofpatiens who received CsA therapy. So the combined therapy is worth to make more widespread.
出处
《实用中西医结合临床》
2013年第1期7-8,共2页
Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
关键词
再生障碍性贫血
中药
环孢素A
联合治疗
Anemia aplastic
Traditional chinese medicine
CsA
Combined therapy
